Inhibitory receptor agonists: the future of autoimmune disease therapeutics?

S Grebinoski, DAA Vignali - Current opinion in immunology, 2020 - Elsevier
Highlights•Inhibitory receptors (IRs) play an important role in limiting autoimmunity.•IR
genetic deletion or antibody blockade exacerbates autoimmunity in mouse models.•SNPs …
被引用次数：41 相关文章
[HTML] nih.gov

[HTML][HTML] Inhibitory receptor agonists: The future of autoimmune disease therapeutics?

S Grebinoski, DAA Vignali - Current opinion in immunology, 2020 - ncbi.nlm.nih.gov
Central and peripheral tolerance both contribute to protection against autoimmunity. The
pathogenesis of autoimmunity, however, can result from critical deficits or limitations in …

Inhibitory receptor agonists: the future of autoimmune disease therapeutics?

S Grebinoski, DA Vignali - Current opinion in immunology, 2020 - pubmed.ncbi.nlm.nih.gov
Central and peripheral tolerance both contribute to protection against autoimmunity. The
pathogenesis of autoimmunity, however, can result from critical deficits or limitations in …

Inhibitory receptor agonists: the future of autoimmune disease therapeutics?

S Grebinoski, DA Vignali - Current Opinion in Immunology, 2020 - europepmc.org
Central and peripheral tolerance both contribute to protection against autoimmunity. The
pathogenesis of autoimmunity, however, can result from critical deficits or limitations in …

[引用][C] Inhibitory receptor agonists: the future of autoimmune disease therapeutics?

S Grebinoski, DAA Vignali - Current Opinion in Immunology, 2020 - cir.nii.ac.jp
Inhibitory receptor agonists: the future of autoimmune disease therapeutics? | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文 …